IDEAYA Biosciences (IDYA) EPS (Weighted Average and Diluted) (2021 - 2025)
IDEAYA Biosciences (IDYA) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with -$0.94 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 39.35% to -$0.94 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.31 through Dec 2025, up 61.01% year-over-year, with the annual reading at -$1.28 for FY2025, 61.9% up from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.94 in Q4 2025 for IDEAYA Biosciences, down from $1.33 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.33 in Q3 2025 to a low of -$1.55 in Q4 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.48 across 5 years, with a median of -$0.52 in 2023.
- Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 1250.0% in 2023 and later skyrocketed 321.67% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.49 in 2021, then fell by 10.2% to -$0.54 in 2022, then grew by 3.7% to -$0.52 in 2023, then plummeted by 198.08% to -$1.55 in 2024, then surged by 39.35% to -$0.94 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for IDYA at -$0.94 in Q4 2025, $1.33 in Q3 2025, and -$0.88 in Q2 2025.